Merck seeks first U.S. authorization for COVID-19 pill

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/29/2026

1. NTAP
2. SPY
3. MDB
4. ORCL
5. MTN
6. AIR
7. NVDA
8. META
9. FFAI
10. SMMT

Go back to Merck seeks first U.S. authorization for COVID-19 pill
Merck & Co. (NYSE: MRK) Delayed: 148.65 -0.04 (0.03%)
Previous Close $148.69    52 Week High $65.46 
Open $148.17    52 Week Low $47.97 
Day High $150.36    P/E 101.12 
Day Low $146.09    EPS $1.47 
Volume 3,459,379